J Pediatr Infect Dis 2020; 15(02): 107-109
DOI: 10.1055/s-0038-1639344
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Moraxella osloensis Bacteremia in an Immunocompetent Child

Prashant Purohit
1   Medical Microbiology Unit, Laboratory Medicine Department, Al-Sabah Hospital, Kuwait
,
Sherif Abdul Latif Sadek
2   Department of Pediatrics, Al-Sabah Hospital, Kuwait
,
Komal Tak
3   Medical Microbiology Unit, Laboratory Medicine Department, Chest Diseases Hospital, Kuwait
,
Maha Emara
1   Medical Microbiology Unit, Laboratory Medicine Department, Al-Sabah Hospital, Kuwait
,
Ritu Bafna
1   Medical Microbiology Unit, Laboratory Medicine Department, Al-Sabah Hospital, Kuwait
,
Ina'am Ahmad Al-Obaid
1   Medical Microbiology Unit, Laboratory Medicine Department, Al-Sabah Hospital, Kuwait
,
Nazima Habibi
4   Kuwait Institute for Scientific Research, Kuwait
,
Abu Salim Mustafa
5   Department of Microbiology, Faculty of Medicine, Kuwait University, Kuwait
› Institutsangaben
Weitere Informationen

Publikationsverlauf

02. Oktober 2017

06. Februar 2018

Publikationsdatum:
16. März 2018 (online)

Abstract

Moraxella osloensis has been reported in the literature as a rare cause of sepsis, central nervous system infection, chest infection, and endophthalmitis. In the present case, the organism was isolated from the blood of an 8-year-old immunocompetent boy. It could not be identified with VITEK-2 and API-20NE (bioMerieux SA, Marcy-l'Etoile, France). Latex-based bacterial antigen test (BD Directigen Meningitis Combo Test; Becton, Dickinson and Company, Sparks, Maryland, United States) was positive for Neisseria meningitidis A/Y. It was identified as M. osloensis using matrix-associated laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF) (Vitek MS, bioMerieux, Marcy-l'Etoile) (confidence level 99.9%) and 16S rRNA gene sequencing (99% sequence identity). The child responded well to ampicillin, and was discharged home after 4 days, on oral amoxicillin–clavulanic acid for the next 7 days. M. osloensis is a rare cause of bacteremia. It may masquerade as N. meningitidis in the routine tests performed in the routine microbiology laboratories. It is imperative to confirm the identification with MALDI-TOF or a molecular method to remove the false positive diagnosis of N. meningitidis, and to avoid the unnecessary use of prophylaxis with rifampicin or ciprofloxacin.

 
  • References

  • 1 Schreckenberger P, Daneshvar M, Hollis D. Acinetobacter, Achromobacter, Chryseobacterium, Moraxella, and other nonfermentative gram-negative rods. In: Murray P, Baron E, Jorgensen J. , et al., eds. Manual of Clinical Microbiology. 9th ed. Washington, DC: American Society for Microbiology; 2007: 749-779
  • 2 Shah SS, Ruth A, Coffin SE. Infection due to Moraxella osloensis: case report and review of the literature. Clin Infect Dis 2000; 30 (01) 179-181
  • 3 Cole JR, Wang Q, Fish JA. , et al. Ribosomal Database Project: data and tools for high throughput rRNA analysis. Nucleic Acids Res 2014; 42 (Database issue): D633-D642
  • 4 Tan L, Grewal PS. Pathogenicity of Moraxella osloensis, a bacterium associated with the nematode Phasmarhabditis hermaphrodita, to the slug Deroceras reticulatum. Appl Environ Microbiol 2001; 67 (11) 5010-5016
  • 5 Parodi E, Galletto C, Vinciguerra T, Stroppiana P, Casonato I, Frigerio M. Neonatal early onset sepsis due to Moraxella osloensis: case-report and revision of the literature. Signa Vitae 2015; 10 (02) 202-207
  • 6 Banks LM, Kurdy NM, Hassan I, Aster AS. Septic arthritis of the ankle due to Moraxella osloensis . Foot Ankle Surg 2007; 13 (04) 189-191
  • 7 Roh KH, Kim CK, Koh E. , et al. Three cases of Moraxella osloensis meningitis: a difficult experience in species identification and determination of clinical significance. J Korean Med Sci 2010; 25 (03) 501-504
  • 8 Walls A, Wald E. Neonatal Moraxella osloensis ophthalmia. (Letter) Emerg Infect Dis 2005; 11 (11) 1803-1804
  • 9 Han XY, Tarrand JJ. Moraxella osloensis blood and catheter infections during anticancer chemotherapy: clinical and microbiologic studies of 10 cases. Am J Clin Pathol 2004; 121 (04) 581-587
  • 10 Lee WS, Hsueh PR, Yu FL, Chen FL, Hsieh TC, Ou TY. Moraxella osloensis bacteremia complicating with severe pneumonia in a patient with lung cancer. J Microbiol Immunol Infect 2017; 50 (03) 395-396
  • 11 Hadano Y, Ito K, Suzuki J, Kawamura I, Kurai H, Ohkusu K. Moraxella osloensis: an unusual cause of central venous catheter infection in a cancer patient. Int J Gen Med 2012; 5: 875-877
  • 12 Sifri CD, Brassinga AKC, Flohr T. , et al. Moraxella osloensis bacteremia in a kidney transplant recipient. Transpl Int 2008; 21 (10) 1011-1013
  • 13 Fijen CAP, Kuijper EJ, Tjia HG, Daha MR, Dankert J. Complement deficiency predisposes for meningitis due to nongroupable meningococci and Neisseria-related bacteria. Clin Infect Dis 1994; 18 (05) 780-784
  • 14 Sugarman B, Clarridge J. Osteomyelitis caused by Moraxella osloensis. J Clin Microbiol 1982; 15 (06) 1148-1149
  • 15 Tiosejo LL, Hocko M, Bartholomew WR, Amsterdam D. Neisseria meningitidis and Moraxella osloensis: dual infection in blood and peritoneal fluid. Diagn Microbiol Infect Dis 1988; 11 (04) 209-213
  • 16 Gagnard JC, Hidri N, Grillon A, Jesel L, Denes E. Moraxella osloensis, an emerging pathogen of endocarditis in immunocompromised patients?. Swiss Med Wkly 2015; 145: w14185